Diana Treis

Karolinska Institutet

Sweden

Research Interests

Explore related searches

Professors in Sweden Professors in Cancer Biology Cancer Biology professors in Sweden

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (8)

Year:

2025

Year:

2024

Year:

2024

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (9)

Susanne Fransson

University of Gothenburg

SWEDEN

View details

Miklos Gulyas

MD, PhD, associate professor, senior consultant pathologist

Uppsala Universitet Medicinska fakulteten

SWEDEN

View details

Margareta Wilhelm

Associate Professor

Karolinska Institutet

SWEDEN

View details

Anders Ståhlberg

Professor

Göteborgs Universitet

SWEDEN

View details

Jikui Guan

Assistant Professor

University of Gothenburg

SWEDEN

View details

Per Kogner

Professor

Karolinska Institutet

SWEDEN

View details

Tommy Martinsson

Professor

University of Gothenburg

SWEDEN

View details

John Inge Johnsen

Karolinska Institutet

SWEDEN

View details

Malin Wickström

Karolinska University Hospital

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Diana Treis

Research Interests

Explore related searches

Contact this professor

Articles (8)

Targeted inhibition of WIP1 and histone H3K27 demethylase activity synergistically suppresses neuroblastoma growth

The ROCK-1/2 inhibitor RKI-1447 blocks N-MYC, promotes cell death, and emerges as a synergistic partner for BET inhibitors in neuroblastoma.

Long-Lasting Response to Lorlatinib in Patients with ALK-Driven Relapsed or Refractory Neuroblastoma Monitored with Circulating Tumor DNA Analysis.

Multifocal Neuroblastoma and Central Hypoventilation in An Infant with Germline ALK F1174I Mutation

Sustained Response to Entrectinib in an Infant With a Germline ALKAL2 Variant and Refractory Metastatic Neuroblastoma With Chromosomal 2p Gain and Anaplastic Lymphoma Kinase and Tropomyosin Receptor Kinase Activation

Neuroblastoma Heterogeneity, Plasticity, and Emerging Therapies.

High Expression of PPM1D Induces Tumors Phenotypically Similar to TP53 Loss-of-Function Mutations in Mice

<i>PPM1D</i> Is a Therapeutic Target in Childhood Neural Tumors

Collaborators (9)

Susanne Fransson

Miklos Gulyas

Margareta Wilhelm

Anders Ståhlberg

Jikui Guan

Per Kogner

Tommy Martinsson

John Inge Johnsen

Malin Wickström

Make your next move.